Navigation Links
Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr
Date:11/25/2008

CORONA, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the proposed merger between Teva Pharmaceutical Industries, Ltd. and Barr Pharmaceuticals, Inc. The closing of the product acquisition is contingent upon the consummation of Teva's merger with Barr.

The portfolio of products consists of 17 products, including 15 FDA-approved products and 2 development-stage products. Key products in the portfolio include:

        Cyclosporine Capsules and Liquid
        Desmopressin Acetate Tablets
        Glipizide/Metformin HCl Tablets
        Mirtazapine Orally Disintegrating Tablets
        Metoclopramide HCl Tablets

"These products represent a sound complement to our extensive generics portfolio," said Paul Bisaro, President and Chief Executive Officer of Watson. He added, "We anticipate these new generics will have immediate value that we will begin to realize in early 2009."

Under the terms of the agreement, Watson will acquire the portfolio of products for an upfront payment of $36 million and will make additional payments to Teva when certain milestones are met on the development-stage products. Teva will supply the products to Watson under a Manufacturing and Supply Agreement until manufacturing is transferred to Watson or a third party.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, CA, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes generic and specialty brand pharmaceutical products. Watson pursues a growth strategy combining internal product
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... September 15, 2014 Stem cells are ... and can divide (through mitosis) to produce more stem ... of cardiovascular diseases, leukemia (a kind of hematological system ... kidney and other parenchymal organs, etc. , Currently, cord ... amid stem cell upstream sectors and even the whole ...
(Date:9/15/2014)... In addition to hosting, Stone Chiropractic ... Chair massages will be offered by Katherine Smith LLMT, ... homemade jams and muffins. Elaine Bauman from Beauty ... teach about doTERRA Essential Oils while Amira Watters will ... from face-painting to a coloring table and more. ...
(Date:9/15/2014)... 15, 2014 Ticketability.com can offer online customers ... Toyota Center, and Smoothie King Center. Fans are happy to ... first headlining tour in a period of three years. , ... 2014 concerts at Ticketability.com. , Colorado concertgoers who reside in ... 1st Bank Center. Texas fans have two chances to see ...
(Date:9/15/2014)... 2014 Recently, Top 10 Best ... compared many web hosting companies and announced that ... best suppliers for webmasters from all over the ... hosting plan. The company’s approach to hosting is ... accessible and powerful enough for anyone to use. ...
(Date:9/15/2014)... With a simple swab of the cheek, ... insight to help personalize the treatment for patients with vascular ... ideal approach to medicine is preventive care. But, it can ... will respond to specific drugs. A simple cheek swab test ... the physician to tailor medical therapy and optimize outcomes. , ...
Breaking Medicine News(10 mins):Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Stone Chiropractic Brings Local Businesses Together for a Community Fall Festival 2Health News:Stone Chiropractic Brings Local Businesses Together for a Community Fall Festival 3Health News:Ticketability.com Unleashes 2014 Usher Tickets for 1st Bank Center, American Airlines Center, Toyota Center, and Smoothie King Center Concerts 2Health News:Top 10 Best SEO Hosting: Justhost And Bluehost Are The Best Suppliers For Webmasters 2Health News:Center for Vascular Medicine Offers Genetic Testing For Personalized Vascular Care 2
... that combination asthma therapy, SYMBICORT leads to significant ... greater patient-reported satisfaction with asthma treatment, versus ... ,SYMBICORT is a recently approved, combination therapy ... in patients 12 years of age and older. ...
... imaging technique - magnetic resonance elastography (MRE) - is an ... ,The studies were conducted by a team of ... ,As part of one study, researchers conducted MRE examinations of ... ,The researchers found that MRE accurately detects ...
... bumps and bruises to contribute to a hostile ... harms another individual, through the manipulation of ... significant a concern for adolescent psychosocial development and ... Montclair State University and her colleagues from the ...
... joined forces with Canadian biotech company GangaGen Life Sciences ... food poisoning . ,They are engaging in ... control of Campylobacter the commonest cause of infectious ... the Health Protection Agency. Campylobacters are found in poultry ...
... Alzheimers one more breakthrough has been achieved. Scientists in New ... of mice using a magnetic stimulus in the region ... at the American Academy for Neuroscience conference. If proven, the ... Alzheimers disease, if not a cure. ,Experts ...
... A new study has found that obese patients with asthma ... those who are not overweight . ,The study ... Fernando Holguin and colleagues at Emory University. ,As ... than 3,000 adults by examining a data from the four-state ...
Cached Medicine News:Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:Psychological Bullying Hits Just as Hard 2Health News:Experts to Develop New Weapons Against Food Poisoning 2Health News:Experts to Develop New Weapons Against Food Poisoning 3Health News:Magnets to the rescue of Alzheimers patients 2Health News:Obesity Might Lead to Severe Persistent Asthma Attacks: Study 2
(Date:9/12/2014)... --  Quest Diagnostics (NYSE: DGX ), ... celebrates a decade on the North America Dow Jones ... World DJSI. The Dow Jones Sustainability ... economic, environmental and social criteria. To be included or ... sustainability initiatives. "A sustainable business is a ...
(Date:9/12/2014)... 12, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... focused on chronic inflammatory disease and neurologic disorders, ... from the U.S. Food and Drug Administration (FDA) ... (NDIN) for the formulations of Anatabloc® and CigRx® submitted ... indicated that the FDA considers anatabine citrate, a principal ...
(Date:9/11/2014)... Fla. , Sept. 11, 2014 ... cancer-treatment research and development firm, has discovered substances ... sediment samples that were recovered from the ocean ... and Recovery Limited Partnership. Logo - ... exciting as the discovery of Gold Rush-era treasure ...
Breaking Medicine Technology:Quest Diagnostics Marks 10 Years on the Dow Jones Sustainability Index 2Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 2Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 3Odyssey Marine Exploration and Morphogenesis discover biotech 'treasures' in the deep 2Odyssey Marine Exploration and Morphogenesis discover biotech 'treasures' in the deep 3
... Detect™ IgM Capture ELISA is for the ... WNV recombinant antigens (WNRA) in serum as ... of West Nile virus infection in patients ... results must be confirmed by Plaque Reduction ...
Adult; dilates 6.0 to 34.0 French; individually packaged, sterile....
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: